The global digital X-ray market is projected to grow from $5.79 billion in 2025 to $9.90 billion by 2036, expanding at a 5.09% CAGR. Growth is driven by the transition from analog to digital systems, adoption of mobile and retrofit solutions, AI-enabled workflows, and detector innovations. North America leads the market, while Asia-Pacific presents significant expansion opportunities. Key challenges include workforce shortages and integration complexity.

The global mobile X-ray systems market is projected to grow from $2.06 billion in 2025 to $4.00 billion by 2036, with a CAGR of 6.30%. Growth is driven by rising chronic disease prevalence, increasing hospitalization rates, and demand for point-of-care imaging. Digital systems dominate with 91.57% market share, while handheld/ultra-portable systems are the fastest-growing segment. Asia-Pacific leads regional growth at 7.43% CAGR, followed by North America and Europe.

The global mobile C-arm market is projected to grow from $2.09 billion in 2025 to $3.71 billion by 2036, expanding at a 5.35% CAGR. Growth is driven by rising adoption of minimally invasive surgery, AI integration, 3D imaging, and aging populations. North America leads the market, with hospitals as the primary end-users. Key challenges include high capital costs and shortage of skilled professionals, while advanced storage and archiving capabilities present significant growth opportunities.

Saudi Arabia's air purifier market is projected to grow from US$199.82 million in 2025 to US$369.22 million by 2034, with a CAGR of 7.06%. Growth is driven by increasing awareness of indoor air quality, frequent dust storms, rapid urbanization, respiratory health concerns, and Vision 2030 infrastructure projects. Portable HEPA purifiers dominate the market, with Riyadh and Jeddah leading regional demand. Key challenges include high purchase prices, filter replacement costs, and consumer knowledge gaps.

The global Pacemaker/Defibrillator Lead Extraction Kit market is projected to grow from USD 1.03 billion in 2025 to USD 1.92 billion by 2034, expanding at a CAGR of 7.2%. Growth is driven by rising CIED implantation volumes, increasing device-related infections, aging populations, and the shift toward minimally invasive procedures. Mechanical extraction systems lead with 46% market share, while hospitals account for 85% of revenue. North America dominates with 44% market share, while Asia-Pacific is expected to record the fastest regional growth.

The global Cardiorespiratory Assessment Units Market is projected to grow from USD 1.48 billion in 2025 to USD 2.98 billion by 2035, expanding at a CAGR of 7.23%. Growth is driven by rising prevalence of COPD and heart failure, innovation in portable AI-enabled systems, and expanding remote care applications. However, high equipment costs and staffing requirements remain challenges. North America leads with 35.12% market share.

Exor N.V. has launched a €500 million share buyback program to reduce share capital, starting with a first tranche of €125 million expected to be completed by end of November 2026. The program will be executed through a discretionary buyback agreement with a financial institution in compliance with market regulations.

The global Software as a Medical Device (SaMD) market is projected to grow from USD 2.10 billion in 2025 to USD 8.90 billion by 2034, expanding at a CAGR of 17.4%. Growth is driven by AI-enabled diagnostics, digital therapeutics, cloud-based deployment, and maturing regulatory pathways. Diagnostic and screening software leads with 42% market share, while radiology applications dominate at 34%. North America holds 45% of the market, with Asia-Pacific expected to record the fastest growth.

The global Ultrasound AI market is projected to grow from USD 2.09 billion in 2025 to USD 22.03 billion by 2035, with a CAGR of 26.62%. Growth is driven by deep learning advancements, point-of-care imaging adoption, and sonographer shortages. North America leads with 45.54% market share, while Asia-Pacific shows the fastest growth at 28.57% CAGR. Hardware dominates at 48% market share, with software as the fastest-growing segment.

The Enterprise Imaging Solutions Market is projected to grow from USD 2.32 billion in 2025 to USD 6.69 billion by 2035, with a CAGR of 11.18%. Growth is driven by cloud-native platforms, AI-driven workflows, and vendor consolidation. North America leads with 44% market share, while Asia-Pacific shows the fastest growth at 15% CAGR. Software remains the largest component at 58% share, with cloud deployment and services as the fastest-growing segments.

Philips launched the eV14-2v transvaginal transducer for gynecology and early obstetrics imaging, offering 41.7% greater penetration, 10% higher resolution, and a 22% lighter design compared to its predecessor. The FDA-cleared device integrates with Philips' Collaboration Live platform for real-time remote consultations. The global obstetrics & gynecology ultrasound market is projected to grow from $2.13 billion in 2024 to $2.84 billion by 2030 at a 4.94% CAGR.

Royal Philips announced the successful pricing of EUR 650 million fixed rate notes due 2034 under its EMTN program, marking the healthcare industry's first EU Green Bond under the new European Green Bond Standard. The 7.8-year tranche was oversubscribed 2.7 times with a 4.0% coupon and 4.055% yield. The company maintains strong investment grade ratings across major agencies.